Woodard & CO Asset Management Group Inc Zoetis Inc. Transaction History

Woodard & CO Asset Management Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$181.39 - $234.03 $951,390 - $1.23 Million	-5,245 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$189.29 - $209.69 $24,986 - $27,679	-132 Reduced 2.45%	5,245 $1.02 Million
Q2 2021 Aug 02, 2021	SELL	$155.9 - $187.99 $4,053 - $4,887	-26 Reduced 0.48%	5,377 $1 Million
Q1 2021 Apr 26, 2021	BUY	$144.0 - $169.39 $158,544 - $186,498	1,101 Added 25.59%	5,403 $851,000
Q4 2020 Feb 03, 2021	BUY	$157.07 - $174.35 $117,645 - $130,588	749 Added 21.08%	4,302 $712,000
Q3 2020 Oct 22, 2020	BUY	$137.1 - $165.37 $21,661 - $26,128	158 Added 4.65%	3,553 $588,000
Q2 2020 Jul 24, 2020	BUY	$111.92 - $142.53 $379,968 - $483,889	3,395 New	3,395 $465,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Woodard & CO Asset Management Group Inc , based on Form 13F filings with the SEC.

Stay updated on Woodard & CO Asset Management Group Inc with notifications on news.